ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Hydromorphone Mundipharma Retard 16 mg, Retardkapseln - 60
70347006 CMMundipharma Medical Company, Hamilton, Bermuda, Basel Branch
Hydromorphone Mundipharma Retard 16 mg, Retardkapseln18.07.2025
  18.07.2025
Hydromorphone (N02AA03) 
WHO-DDD 
60
01.01.30. 
A+  
No 
  
PR  
k.A.PR
  
7680703470060Synthetika
  
Composition
hydromorphoni hydrochloridum 16 mg corresp. hydromorphonum 14.19 mg, cellulosum microcristallinum, hypromellosum, ethylcellulosum, silica colloidalis anhydrica, dibutylis sebacas, Kapselhülle: gelatina, natrii laurilsulfas corresp. natrium 0.012 mg, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.
Packungsbestandteile
Delayed release capsules
 
Active AgentDose
Hydromorphon Hydrochloride16 mg correspond Hydromorphone 14.19 mg
 
Inactive agents additional_information
   
   
   
   
   
  color.
  color.
   
Gelatina Kapselhülle
Hypromellosum  
  Drucktinte
   
   
Propylenglycol  
Silica Colloidalis Anhydrica  
Source
Data was imported : 07.08.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home